Nivolumab-induced autoantibody negative limbic encephalitis in a patient with Hodgkin lymphoma
Author:
Affiliation:
1. Department of Neurology, Haydarpasa Numune Training and Research Hospital, Saglik Bilimleri University, Istanbul, Turkey;
2. Department of Neuroscience, Aziz Sancar Institute for Experimental Medicine, Istanbul University, Istanbul, Turkey
Publisher
Informa UK Limited
Subject
Cancer Research,Oncology,Hematology
Link
https://www.tandfonline.com/doi/pdf/10.1080/10428194.2020.1725508
Reference15 articles.
1. The future of immune checkpoint therapy
2. FDA Approval Summary: Nivolumab for the Treatment of Relapsed or Progressive Classical Hodgkin Lymphoma
3. A review of serious adverse effects under treatment with checkpoint inhibitors
4. Neurologic Serious Adverse Events Associated with Nivolumab Plus Ipilimumab or Nivolumab Alone in Advanced Melanoma, Including a Case Series of Encephalitis
5. Increased frequency of anti-Ma2 encephalitis associated with immune checkpoint inhibitors
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Immune Checkpoint Inhibitors in Hodgkin Lymphoma and Non-Hodgkin Lymphoma;Immune Checkpoint Inhibitors - New Insights and Recent Progress;2023-03-08
2. Immune Mechanism of Epileptogenesis and Related Therapeutic Strategies;Biomedicines;2022-03-19
3. Autoimmune and Inflammatory Encephalopathies as Complications of Cancer;Autoimmune Encephalitis and Related Disorders of the Nervous System;2022-01-31
4. Encephalitis Induced by Immune Checkpoint Inhibitors;JAMA Neurology;2021-07-01
5. Nivolumab;Reactions Weekly;2020-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3